CLINICAL_TRIALS
trial_result
· 2018-08-16
Clinical Trial Update: Empa/Lina FDC Food Effect Study (Japan) [Phase 1]
Summary
Phase 1 food effect study of Empagliflozin/Linagliptin fixed-dose combination conducted in Japan has completed; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2018-08-16